MMJ The Voice DEA Didn't Want to Hear From During Marijuana Rescheduling Hearings

MMJ The Voice DEA Didn't Want to Hear From During Marijuana Rescheduling Hearings

" DEA silenced the only FDA-pathway cannabinoid developer at its ALJ hearing. The courts won't." - Duane Boise, CEO, MMJ International Holdings.

Jason Adelstone to Speak on DEA Marijuana Rescheduling Hearing

The DEA's marijuana rescheduling hearing continues to raise important questions for cannabis businesses, investors, and the industry as a whole. If you're trying to keep up with where things stand and what may come next, this upcoming MJBizDaily webinar is worth your time. Harris Sliwoski attorney Jason Adelstone will join a panel of industry professionals to discuss the latest developments from the hearing, what Schedule III rescheduling could …